Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI3A12
| Applications | ELISA |
| Reactivities | Human |
ELISA Kits
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI2H9
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI2D1
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI5C8
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) S100B mouse monoclonal antibody, clone OTI1G6
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI2D4
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI3F3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI1A7
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI2G10
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GFAP mouse monoclonal antibody, clone OTI10B2
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI1D11
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI6B3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI8H3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI6C3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI2G2
| Applications | ELISA |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Target Symbol
- PGP9.5 (30)
- GFAP (25)
- NEUROFILAMENT (18)
- MYBPC3 (15)
- B7-1 (12)
- MYELOPEROXIDASE (12)
- IL17 (11)
- D-DIMER (10)
- IGG4 (10)
- NGAL (10)
- S100 BETA (10)
- ST2 (10)
- FABP3 (9)
- N PROTEIN (9)
- PD-L1 (9)
- PD1 (9)
- REG1 ALPHA (9)
- S PROTEIN (9)
- S100A8/A9 (9)
- SARS-COV-2 N PROTEIN (9)
- SARS-COV-2 SPIKE PROTEIN (9)
- SERUM AMYLOID A (9)
- IL6 (7)
- BETA 2 MICROGLOBULIN (6)
- PON1 (6)
- PSMA (6)
- S100A1 (6)
- B RAF (3)
- MSMB (3)
- MAGEA3 (1)
- S100A8/S100A9 (1)
- VIMENTIN (1)
Reactivities
Applications
Antibody Hosts
Knockout (KO) Validation
Isotypes
Clonalities
Assay Types
Families
Pathways
- Cell adhesion molecules (CAMs) (30)
- Parkinson's disease (30)
- Hypertrophic cardiomyopathy (HCM) (22)
- Graft-versus-host disease (19)
- Toll-like receptor signaling pathway (19)
- Amyotrophic lateral sclerosis (ALS) (18)
- Cytokine-cytokine receptor interaction (18)
- Dilated cardiomyopathy (15)
- Allograft rejection (12)
- Autoimmune thyroid disease (12)
- Systemic lupus erythematosus (12)
- Type I diabetes mellitus (12)
- Viral myocarditis (12)
- Pathways in cancer (10)
- PPAR signaling pathway (9)
- T cell receptor signaling pathway (9)
- Cytosolic DNA-sensing pathway (7)
- Hematopoietic cell lineage (7)
- Jak-STAT signaling pathway (7)
- NOD-like receptor signaling pathway (7)
- Prion diseases (7)
- Antigen processing and presentation (6)
- Metabolic pathways (6)
- Acute myeloid leukemia (3)
- Bladder cancer (3)
- Chemokine signaling pathway (3)
- Chronic myeloid leukemia (3)
- Colorectal cancer (3)
- Endometrial cancer (3)
- ErbB signaling pathway (3)
- Focal adhesion (3)
- Glioma (3)
- Insulin signaling pathway (3)
- Long-term depression (3)
- Long-term potentiation (3)
- MAPK signaling pathway (3)
- Melanoma (3)
- Natural killer cell mediated cytotoxicity (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Progesterone-mediated oocyte maturation (3)
- Prostate cancer (3)
- Regulation of actin cytoskeleton (3)
- Renal cell carcinoma (3)
- Thyroid cancer (3)
- Vascular smooth muscle contraction (3)
- mTOR signaling pathway (3)
